Response to press speculation

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

Oxford Biomedica plc

Response to press speculation and share price movement

The Board of Oxford Biomedica plc ("OXB" or the "Group") (LSE: OXB) notes the recent press speculation and share price movement and confirms that it has received an unsolicited approach from EQT X EUR SCSp and EQT X USD SCSp each represented by its manager (gérant), EQT Fund Management S.à r.l. (collectively referred to as "EQT") regarding a possible cash offer for the entire issued and to be issued ordinary share capital of OXB. The Group and EQT are now in preliminary discussions to explore whether a proposal can be made at a level that the Board would be minded to recommend.

The discussions follow earlier unsolicited proposals from EQT regarding a possible acquisition of OXB. The Board of OXB, together with its advisers, carefully considered the earlier proposals and rejected them on the basis that they undervalued OXB and its prospects.

There can be no certainty that any firm offer for OXB will be made nor as to the terms on which any firm offer might be made. Accordingly, OXB shareholders are strongly advised to take no action at this time.

In accordance with Rule 2.6(a) of the Code, EQT is required, by not later than 5.00 p.m. (London time) on 11 February 2026, to either announce a firm intention to make an offer for OXB in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel") in accordance with Rule 2.6(c) of the Code.

The attention of shareholders is drawn to the disclosure requirements of Rule 8 of the Code, which are summarised below.

UK MAR

RULE 2.9 INFORMATION

The International Securities Identification Number for the Ordinary Shares is GB00BDFBVT43.

DISCLOSURE REQUIREMENTS OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified.